Little med-mal risk, psych drug maker says

January 2008
Healthcare Risk Management;Jan2008, Vol. 30 Issue 1, p11
The article reports on the actions taken by Eli Lilly and Co. to reassure psychiatrists they face little malpractice risk for prescribing its antipsychotic drug Zyprexa which is the target of numerous legal claims.


Related Articles

  • Steam accidents injure workers.  // Contractor Magazine;Nov2002, Vol. 49 Issue 11, p14 

    Reports on the investigation of an explosion on October 10, 2002 that injured two people at an Eli Lilly Co. plant in Greenfield, Indiana by the Indiana Occupational Safety and Health Administration. Description of the explosion; Condition of the injured workers.

  • Born-Again Prozac: Not Worth the Extra Cost. Napoli, Maryann // HealthFacts;Jul2001, Vol. 26 Issue 7, p1 

    Announces the move of Eli Lilly company to release a repackaged version and a new dosage form of its antidepressant drug Prozac in the United States.

  • Lilly may wield scalpel on medical devices. Andrews, Greg // Indianapolis Business Journal;11/8/93, Vol. 14 Issue 32, p1 

    Speculates that Eli Lilly & Co. will close down its medical device and diagnostics division due to decreasing sale and sustained losses. Market analysts' predictions; Lilly Co.'s problem with the U.S. Food and Drug Administration; Ouster of Vaugh Bryson, president and chief executive officer...

  • DowElanco may be next to leave Lilly. Andrews, Greg // Indianapolis Business Journal;1/24/94, Vol. 14 Issue 44, p1A 

    Speculates on the termination of the business partnership between Eli Lilly and Co. and DowElanco. Possible effects on Eli Lilly's revenues, sales and stock transactions; Reasons for severance of joint venture; Industry analysts' view on Eli Lilly's move; Framework for the divestment of Eli...

  • Lilly tops industry in charitable support. Maurer, Katie // Indianapolis Business Journal;7/14/2003, Vol. 24 Issue 18, p43 

    Reports on the charitable activities of Eli Lilly & Co.

  • (MENTAL HEALTH) Deadline Extended for Lilly 'Welcome Back' Nominations.  // Community Health Funding Week;12/4/2009, p21 

    The article reports on the extension of the deadline, for sending nominations to the Welcome Back Awards program sponsored by Eli Lilly and Co., till December 16, 2009.

  • Lilly objects to phen-pro promo.  // Drug Topics;10/6/97, Vol. 141 Issue 19, p8 

    Presents information on Eli Lilly & Company. Details on the Nutri/System ad campaign to promote the use of Prozack (fluoxetine) and phentermine for weight loss.

  • Lilly Drugs. Schwarb, John // Indianapolis Monthly;Jul2010, Vol. 33 Issue 13, p20 

    The article presents information on several drugs sold by Eli Lilly and Co. which include Zyprexa, Cymbalta, and Alimta.

  • Commonly used oral antibiotics are recalled.  // Child Health Alert;May94, Vol. 12, p5 

    Reports on the move of Eli Lilly and Company to recall all strengths and package sizes of oral suspensions of Ceclor, Lorabid and Keflex because of the presence of plastic cap inside bottles of oral antibiotics. Move of Eli Lilly as precautionary measure for oral antibiotics users; Possible...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics